Startseite

Buspirone Hydrochloride

Buspirone Hydrochloride

Spezifikationen

33386-08-2CAS-Nummer
251-489-4EG-Nummer
8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;hydrochlorideIUPAC-Name
C21H32ClN5O2Chemische Formel
422 g/molMolekulargewicht
Buspirone hydrochloride; 33386-08-2; Buspirone HCL; Spamilan; MJ 9022-1; NSC-751138; NSC-759571; 207LT9J9OC; APD405; MJ-9022-1; APD-405; N-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-1,1-cyclopentanediacetamide monohydrochloride; CHEBI:3224; DTXSID1037193; 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride; 8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, monohydrochloride; 8-(4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl)-8-azaspiro(4.5)decane-7,9-dione hydrochloride; N-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-1,1-cyclopentanediacetamide monohydrochloride; 8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, monohydrochloride; Hydrochloride, Buspirone; RefChem:57603; DTXCID9017193; MJ90221; MJ 9022 1; 251-489-4; Buspar; Narol; Buspimen; Buspirone (hydrochloride); 8-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)-8-azaspiro[4.5]decane-7,9-dione hydrochloride; MFCD00078569; 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;hydrochloride; MLS000069796; Buspirone.HCl; 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione; 8-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione hydrochloride; Ansitec; Anxinil; Anxiolan; Busirone; Buspinol; Censpar; Effiplen; Establix; Kallmiren; Lucelan; Mabuson; Normaton; SMR000058186; Barpil; Itagil; Nerbet; Sburol; Travin; Tutran; Biron; Relac; Apo-Buspirone; Ansiced; C21H32ClN5O2; Buspirone hydrochloride [USAN]; SR-01000075541; EINECS 251-489-4; UNII-207LT9J9OC; Prestwick_711; Buspirone hydrochloride [USAN:USP]; Buspar (TN); Opera_ID_707; 33386-08-2 (HCl); Buspirone hydrochloride CRS; 1,1-Cyclopentanediacetimide, N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, hydrochloride; 8-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione hydrochloride; N-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride; Buspirone hydrochloride[JAN]; SCHEMBL41495; MLS001076085; MLS002548862; Buspirone hydrochloride (USP); orb1225273; orb1306402; orb3141385; CHEMBL1200399; HY-B1115R; MSK10309A; HMS1569I19; HMS3750O03; HMS5082F20; HMS6019A05; Pharmakon1600-02300173; Buspirone HCl - Bio-X trade mark; APC-6002; APC-6003; HY-B1115; BUSPIRONE HYDROCHLORIDE [MI]; Tox21_500223; Buspirone (hydrochloride) (Standard); Buspirone for system suitability CRS; EBC-14142; HB1649; NSC751138; NSC759571; s4256; AKOS015962019; AC-1905; BUSPIRONE HYDROCHLORIDE [MART.]; BUSPIRONE HYDROCHLORIDE [VANDF]; CCG-213652; CS-4714; FB38586; FP19364; KS-5163; LP00223; NC00673; NSC 751138; NSC 759571; 1,1-Cyclopentanediacetimide, N-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, monohydrochloride; BUSPIRONE HYDROCHLORIDE [USP-RS]; BUSPIRONE HYDROCHLORIDE [WHO-DD]; NCGC00093692-01; NCGC00093692-02; NCGC00260908-01; 8-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-8-azaspiro(4.5)decane-7,9-dione monohydrochloride; 8-Azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, monohydrochloride; B8274; BUSPIRONE HYDROCHLORIDE [ORANGE BOOK]; EU-0100223; NS00076188; ST51014924; SW155073-5; T2132; BUSPIRONE HYDROCHLORIDE [EP MONOGRAPH]; B 7148; BUSPIRONE HYDROCHLORIDE [USP MONOGRAPH]; D00702; D96810; EN300-122362; Buspirone.HCl, 1mg/ml in Methanol (as free base); SR-01000075541-1; SR-01000075541-3; SR-01000075541-7; Q27105997; Z1541759502; Buspirone Hydrochloride 1.0 mg/ml in Methanol (as free base); Buspirone hydrochloride, European Pharmacopoeia (EP) Reference Standard; Buspirone hydrochloride, United States Pharmacopeia (USP) Reference Standard; 8-[4-(4-pyrimidin-2-ylpiperazinyl)butyl]-8-azaspiro[4.5]decane-7,9-dione, chlo ride; 8-Azaspiro[4.5]decane-7, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, monohydrochloride; Buspirone for system suitability, European Pharmacopoeia (EP) Reference Standard; Buspirone hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; 1-[4-(7,9-dioxo-8-azaspiro[4.5]decan-8-yl)butyl]-4-(pyrimidin-2-yl)piperazin-1-ium chloride; 8-[4-[4-(2-Pyrimidinyl)-1-pipirazin yl]butyl]-8-azaspiro[4,5]decane-7,9-dione hydrochloride; 8-[4-[4-(Pyrimidin-2-yl)piperazin-1-yl]butyl]-8-azaspiro[4.5]-decane-7,9-dione hydrochloride; 8-[4-[4-(pyrimidine-2-yl)-piperazine-1-yl]-butyl]-8-aza-spiro[4.5]decane-7,9-dione hydrochloride; 8-{4-[4-(Pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione--hydrogen chloride (1/1); 8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, hydrochloride (1:1)Synonyme